However, dietary changes alone cannot raise GLP-1 levels nearly as much as GLP-1 agonist medications
The ongoing CVOT of tirzepatide (SURPASS-CVOT, NCT04255433) will compare tirzepatide with dulaglutide 1.5 mg/wk to determine efficacy for the primary outcome of 3-point MACE [70]
Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system
In terms of calorie reduction, the survey shows an average ~500 calorie reduction (or ~18.5%) for respondents using GLP-1 drugs, compared to a ~600 calorie reduction (or ~23.1%) for respondents using other weight loss methods
It is often better to stay at your current dose for an additional month to allow your body to fully stabilize before challenging it with a higher concentration
Whether you opt for semaglutide GLP-1 or Zepbound, we ensure you receive the most suitable and safe treatment for your weight loss journey